Benecyte, Inc. Employee Directory
Research ServicesNorth Carolina, United States11-50 Employees
Benecyte, Inc. operates in the research services sector with a focus on cancer immunotherapy. The company centers on an allogeneic CAR-CIK platform intended to treat both liquid and solid tumors, aiming to improve efficacy while reducing toxicity compared with existing therapies. Its work addresses the needs of oncology researchers and clinical developers seeking novel cellular approaches to immune-oncology. Based in Durham, North Carolina, the business appears positioned as a clinical-stage entity exploring next-generation cellular immunotherapies within a private, specialized field. The information notes coIMMUNE as a privately held entity, emphasizing its role in advancing cancer treatment through cellular immunotherapy research and development.